R (ANITA). Niraparib in Combination with Pembrolizumab in Patients with Triple-negative Breast D-Phenothrin Inhibitor cancer
R (ANITA). Niraparib in Combination with Pembrolizumab in Patients with Triple-negative Breast D-Phenothrin Inhibitor...